A proton-activatable aminated-chrysophanol sensitizer for photodynamic therapy
Source abstract
Abstract
Abstract Exploiting the tumor microenvironment provides a new strategy for cancer treatment. In order to develop the microenvironment-selective photosensitiser, we rationally designed a proton-activatable aminated-chrysophanol derivative-compound 3, which combines fluorescence and reactive oxygen species regulated by the tumor acidic microenvironment for the first time. Furthermore, two PET tertiary amine substituents introduced by compound 3 enhance the cellular uptake, prolong the wavelength of the absorption, and increase the phototoxicity. Not only can compound 3 distinguish the cancer cells from normal cells but also the tumor from the normal tissue by the higher fluorescence intensity in cancer cells and tissues. Additionally, lysosome destruction test proves cell necrosis in lysosomal related pathway. We believe that the proton-activatable photosensitiser modulated by tumor acidic microenvironment offers a good chance for the cancer treatment in clinic.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Porphyrin and Phthalocyanine Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (43)
Show source-provided references
1. Activatable photosensitizers for imaging and therapy10.1021/cr900236h ↗
2. A review of stimuli-responsive nano carriers for drug and gene delivery10.1016/j.jconrel.2007.12.017 ↗
3. Acidic extracellular microenvironment and cancer10.1186/1475-2867-13-89 ↗
4. A pH-activatable and aniline-substituted photosensitizer for near-infrared cancer theranostics10.1039/C5SC01721A ↗
5. pH-Sensitive self-assembling nanoparticles for tumor near-infrared fluorescence imaging and chemo–photodynamic combination therapy10.1039/C5NR06842H ↗
6. AIE-active theranostic system: selective staining and killing of cancer cells10.1039/C6SC04947H ↗
7. Tumor microenvironment-responsive charge reversal zinc phthalocyanines based on amino acids for photodynamic therapy10.1016/j.dyepig.2015.12.009 ↗
8. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization10.1021/cr900300p ↗
9. Photosensitizers of the porphyrin and phthalocyanine series for-photodynamic therapy10.1039/cs9952400019 ↗
10. Peptide-modulated self-assembly of chromophores toward biomimetic light-harvesting nanoarchitectonics10.1002/adma.201502454 ↗
11. Multifunctional nano-bioprobes based on rattle-structured upconverting luminescent nanoparticles10.1002/anie.201501468 ↗
12. Chen · Two-dimensional graphene analogues forbiomedical applications Chem Soc Rev · 2015 · 44 · 2681
13. Photodynamic therapy and anti-tumour immunity
14. light-triggered theranostics based on photosensitizer- conjugated carbon dots for simultaneous enhanced- fluorescence imaging and photodynamic therapy
15. Cell-specific and pH-activatable rubyrin-loaded nanoparticles for highly selective near-infrared photodynamic therapy against cancer10.1021/ja408286k ↗
16. PEG-functionalized iron oxide nanoclusters loaded with chlorin e6 for targeted, NIR light induced, photodynamic therapy10.1016/j.biomaterials.2013.08.041 ↗
17. Intranuclear photosensitizer delivery and photosensitization for enhanced photodynamic therapy with ultralow irradiance10.1002/adfm.201402255 ↗
18. Polyion complex vesicles for photoinduced intracellular delivery of amphiphilic photosensitizer10.1021/ja406992w ↗
19. A bifunctional photosensitizer for enhanced fractional photodynamic therapy singlet oxygen generation in the presence and absence of light10.1002/anie.201511345 ↗
20. Polymeric nanoparticle-based activatable near-infrared nanosensor for protease determination in vivo10.1021/nl902709m ↗
21. A lysosome-targeted BODIPY as potential NIR photosensitizer for photodynamic therapy10.1016/j.dyepig.2017.07.048 ↗
22. Facile self-assembly of porphyrin-embedded polymeric vesicles for theranostic applications10.1039/c2cc33851c ↗
23. Site-selective multi-porphyrin attachment enables the formation of a next-generation antibody-based photodynamic therapeutic10.1039/C5CC06985H ↗
24. Simple peptide-tuned self-assembly of photosensitizers towards anticancer photodynamic therapy10.1002/anie.201509810 ↗
25. Current clinicaland preclinical photosensitizers for use in photodynamic therapy10.1021/jm040074b ↗
26. Research progress on the phthalocyanine based targeting photosensitizers in photodynamic therapy10.6023/A16100553 ↗
27. In vivo tumor diagnosis and photodynamic therapy via tumoral pH-responsive polymeric micelles10.1039/c0cc01413c ↗
28. Photodynamic therapy of oligoethylene glycol dendronized reduction-sensitive porphyrins
29. C-Phycocyanin as a tumour-associated macrophage-targeted photosensitiser and a vehicle of phthalocyanine for enhanced photodynamic therapy10.1039/C6CC09541K ↗
30. Pluronic micelle-encapsulated red-photoluminescent chlorophyll derivative for biocompatible cancer cell imaging10.1016/j.dyepig.2016.08.018 ↗
31. A TD-DFT study on the photo-physicochemical properties of chrysophanol from rheum10.3390/ijms10073186 ↗
32. The natural retinoprotectant chrysophanol attenuated photoreceptor cell apoptosis in an N-methyl-N-nitrosourea-induced mouse model of retinal degeneration10.1038/srep41086 ↗
33. Chrysophanol inhibits NALP3 inflammasome activation and ameliorates cerebral ischemia/reperfusion in mice
34. Supramolecular photonic therapeutic agents10.1021/ja0553497 ↗
35. Modulation of ROS production in photodynamic therapy using a pH controlled photoinduced electron transfer (PET) based sensitiser10.1039/C5CC07022H ↗
36. An “enhanced PET”-based fluorescent probe with ultrasensitivity for imaging basal and elesclomol-induced HClO in cancer cells10.1021/ja505988g ↗
37. d-PET-controlled “off-on” polarity-sensitive probes for reporting local hydrophilicity within lysosomes10.1038/srep35627 ↗
38. Fluorescent PET (Photoinduced Electron Transfer) sensors as potent analytical tools10.1039/b912527m ↗
39. Thinking outside the silicon box: molecular and logic as an additional layer of selectivity in singlet oxygen generation for photodynamic therapy10.1021/ja808389t ↗
40. Proof of principle for a molecular 1:2 demultiplexer to function as an autonomously switching theranostic device10.1039/C2SC21499G ↗
41. In vitro photodynamic studies of a BODIPY-based photosensitizer10.1002/ejoc.201601054 ↗
42. Metalloporphyrin-Encapsulated biodegradable nanosystems for highly efficient magnetic resonance imaging-guided sonodynamic cancer therapy10.1021/jacs.6b11846 ↗
43. Cell-specific and pH-activatable rubyrin-loaded nanoparticles for highly selective near-infrared photodynamic therapy against cancer10.1021/ja408286k ↗